CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 6,250 shares at $8.00 ($50,000)
- 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
- 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
- 4 Open-market buy President and CEO bought 12,500 shares at $8.00 ($100,000)
- 4 Open-market buy Director bought 9,375 shares at $8.00 ($75,000)
- 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
- 4 Derivatives Options or other derivatives
- 4 Conversion 10% owner acquired 21,250 shares (conversion)
- 4 Option exercise 10% owner acquired 72,690 shares (option exercise)
- 4 Conversion 10% owner acquired 9,208 shares (conversion)
- 4 Option exercise 10% owner acquired 121,152 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 11 of 12 · 223 filings